Regarding neuroimaging measures, white matter changes have been suggested as a biomarker for the early identification of AD [131], and alterations in the UF, CI, and ILF white matter microstructure have previously been found in AD patients [131–133]. This evidence concerns the gene FOXK2 and Alzheimer disease.